Ms. Weiner serves as Sr. VP, Diagnostics, responsible for Prometheus Biosciences’ diagnostic strategies. Most recently, she served as Sr. VP, Regulatory and Quality at Agendia. Prior to this position, Ms. Weiner served as Sr. VP, Corporate Governance and Regulatory at Sequenom from 2010 to 2016 until its acquisition by Laboratory Corporation of America. Ms. Weiner served as Vice President, Regulatory and Government Affairs at Biosite from 2004 to 2007 until its acquisition by Alere. From 1982 to 2004, she held positions of increasing responsibility at Quidel Corporation, most recently serving as Vice President, Clinical and Regulatory. Ms. Weiner also held positions at Scripps Clinic and Research Foundation and UCSD.